Tuminello, Stephanie
Alpert, Naomi
Veluswamy, Rajwanth R.
Kumar, Arvind
Gomez, Jorge E.
Flores, Raja
Taioli, Emanuela
Article History
Received: 13 July 2021
Accepted: 20 December 2021
First Online: 19 January 2022
Declarations
:
: This study was determined to be human subject research exempt by the institutional review board of Mount Sinai Hospital.
: Not Applicable.
: Rajwanth Veluswamy has received consulting honorarium from Onconova Pharmaceuticals. All the other authors have no interests to disclose.